Does chronic opioid therapy alter the pattern of sleep apnea? Source: Eur Respir J 2004; 24: Suppl. 48, 446s Year: 2004
The effects of opioids on perioperative outcomes in patients with obstructive sleep apnoea Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016
The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Refractory sleep disordered breathing associated with chronic opioid therapy Source: Eur Respir J 2001; 18: Suppl. 33, 88s Year: 2001
Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007
Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021
Daytime sleepiness in patients on intrathecal chronic opioid (IT) therapy is not related to sleep disordered breathing (SDB) Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011
Role of common hypnotics on the phenotypic causes of obstructive sleep apnoea: paradoxical effects of zolpidem Source: Eur Respir J, 50 (6) 1701344; 10.1183/13993003.01344-2017 Year: 2017
Impact of bi-Level ventilation on sleep disordered breathing in patients using chronic opioids Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010
Efficacy and safety of modafinil as an adjunctive therapy for excessive sleepiness associated with obstructive sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 116s Year: 2004
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021
Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021
Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy? Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020
CPAP in the elderly with non-severe obstructive sleep apnea: effect on cardiovascular events and somnolence. Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
Effect of nCPAP-therapy to depressive symptoms in patients with obstructive sleep apnea Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010
The use of systemic corticosteroids in children with obstructive sleep apnea syndrome Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019
Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma Source: International Congress 2019 – Asthma education: lifestyle and adolescence Year: 2019
Obstructive sleep apnea syndrome and insomnia: The development of insomnia symptoms with CPAP treatment Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017
Differences between commercial vehicle drivers and other patients in symptoms of obstructive sleep apnoea and response to CPAP therapy Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012